Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results-Reference-Cited by-同舟云学术

Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results

Published:2024-04 Issue:4 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Ribera Josep‐Maria¹^ORCID,Morgades Mireia¹,Ribera Jordi¹,Montesinos Pau²,Cano‐Ferri Isabel²,Martínez Pilar³,Esteve Jordi⁴,Esteban Daniel¹,García‐Fortes María⁵,Alonso Natalia⁶,González‐Campos José⁷,Bermúdez Arancha⁸,Torrent Anna¹,Genescà Eulàlia¹,Maluquer Clara⁹,Martínez‐López Joaquín³,García‐Sanz Ramón¹⁰

Affiliation:

1. Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain

2. Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain

3. Department of Hematology Hospital Doce de Octubre Madrid Spain

4. Department of Hematology Hospital Clínic Barcelona Spain

5. Department of Hematology Hospital Universitario Virgen de la Victoria Málaga Spain

6. Department of Hematology Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain

7. Department of Hematology Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla Sevilla Spain

8. Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain

9. Department of Hematology, ICO‐Hospital Duran i Reynals Hospitalet de Llobregat Spain

10. Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) CIBERONC and Center for Cancer Research‐IBMCC (USAL‐CSIC) Salamanca Spain

Funder

Innovative Medicines Initiative

Instituto de Salud Carlos III

Centres de Recerca de Catalunya

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.67

Reference12 articles.

1. Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

2. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study

3. INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia

4. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

5. Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Immunotherapy in first line treatment of adult acute lymphoblastic leukemia;Current Opinion in Oncology;2024-08-13